NO20000229L - Behandling av diabetes med tiazolidindion og sulfonylurea - Google Patents

Behandling av diabetes med tiazolidindion og sulfonylurea

Info

Publication number
NO20000229L
NO20000229L NO20000229A NO20000229A NO20000229L NO 20000229 L NO20000229 L NO 20000229L NO 20000229 A NO20000229 A NO 20000229A NO 20000229 A NO20000229 A NO 20000229A NO 20000229 L NO20000229 L NO 20000229L
Authority
NO
Norway
Prior art keywords
thiazolidinedione
sulfonylurea
diabetes
treatment
Prior art date
Application number
NO20000229A
Other languages
English (en)
Other versions
NO20000229D0 (no
NO326356B1 (no
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10816177&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20000229(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20000229D0 publication Critical patent/NO20000229D0/no
Publication of NO20000229L publication Critical patent/NO20000229L/no
Publication of NO326356B1 publication Critical patent/NO326356B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20000229A 1997-07-18 2000-01-17 Kombinasjon av tiazolidindion og sulfonylurea samt anvendelse derav og farmasoytisk blanding. NO326356B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9715306A GB9715306D0 (en) 1997-07-18 1997-07-18 Novel method of treatment
PCT/GB1998/002109 WO1999003476A1 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione and sulphonylurea

Publications (3)

Publication Number Publication Date
NO20000229D0 NO20000229D0 (no) 2000-01-17
NO20000229L true NO20000229L (no) 2000-01-17
NO326356B1 NO326356B1 (no) 2008-11-17

Family

ID=10816177

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000229A NO326356B1 (no) 1997-07-18 2000-01-17 Kombinasjon av tiazolidindion og sulfonylurea samt anvendelse derav og farmasoytisk blanding.

Country Status (41)

Country Link
EP (1) EP0998291B2 (no)
JP (2) JP2001510158A (no)
KR (1) KR100680667B1 (no)
CN (1) CN1264302A (no)
AP (1) AP1318A (no)
AR (2) AR016768A1 (no)
AT (1) ATE366577T1 (no)
AU (1) AU743269B2 (no)
BG (1) BG64892B1 (no)
BR (1) BR9810904A (no)
CA (1) CA2297115C (no)
CO (1) CO4940422A1 (no)
CY (1) CY1107745T1 (no)
CZ (1) CZ302668B6 (no)
DE (1) DE69838066T3 (no)
DK (1) DK0998291T4 (no)
DZ (1) DZ2564A1 (no)
EA (1) EA003303B1 (no)
ES (1) ES2290989T5 (no)
GB (1) GB9715306D0 (no)
HK (1) HK1029272A1 (no)
HU (1) HU229119B1 (no)
ID (1) ID24198A (no)
IL (1) IL134045A0 (no)
IN (1) IN189035B (no)
MA (1) MA26522A1 (no)
MY (1) MY138246A (no)
NO (1) NO326356B1 (no)
NZ (3) NZ520652A (no)
OA (1) OA11632A (no)
PE (1) PE99799A1 (no)
PL (2) PL199125B1 (no)
PT (1) PT998291E (no)
SI (1) SI0998291T2 (no)
SK (2) SK287823B6 (no)
TR (1) TR200000135T2 (no)
TW (1) TW586926B (no)
UA (1) UA70302C2 (no)
UY (1) UY25103A1 (no)
WO (1) WO1999003476A1 (no)
ZA (1) ZA986365B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1832291A3 (en) * 1999-07-13 2009-11-04 Medicure Inc. use of pyridoxal phosphate for the treatment of diabetes and related complications
EP1897547A1 (en) * 1999-07-13 2008-03-12 Medicure Inc. Use of pyridoxal phosphate derivatives for the treatment of diabetes and related complications
US6586438B2 (en) 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
US20010036479A1 (en) 2000-01-14 2001-11-01 Gillian Cave Glyburide composition
CA2434169C (en) 2001-01-12 2011-03-15 Sun Pharmaceutical Industries Limited Spaced drug delivery system
WO2005041962A1 (en) 2003-10-31 2005-05-12 Takeda Pharmaceutical Company Limited Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
JP2008019169A (ja) * 2004-10-25 2008-01-31 Osaka Univ 新規ｐｐａｒ調節剤およびそのスクリーニング方法
CA2633149C (en) 2005-12-22 2015-06-30 Takeda Pharmaceutical Company Limited Solid preparation containing an insulin sensitizer

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
US5061717A (en) * 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
MX15171A (es) * 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
US5183823A (en) * 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
ES2089474T3 (es) * 1991-08-16 1996-10-01 Sandoz Ltd Inhalador para la administracion de sustancias en polvo.
AU2479492A (en) * 1991-08-26 1993-03-16 Upjohn Company, The Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes

Also Published As

Publication number Publication date
DK0998291T4 (da) 2011-09-26
PE99799A1 (es) 1999-12-22
CA2297115C (en) 2010-02-23
DE69838066D1 (de) 2007-08-23
AR019331A2 (es) 2002-02-13
AP2000001734A0 (en) 2000-03-31
AU743269B2 (en) 2002-01-24
JP2001510158A (ja) 2001-07-31
NZ515555A (en) 2002-09-27
AR016768A1 (es) 2001-08-01
HU229119B1 (en) 2013-08-28
BG104139A (en) 2000-11-30
NO20000229D0 (no) 2000-01-17
EP0998291B2 (en) 2011-07-06
ES2290989T3 (es) 2008-02-16
PL199125B1 (pl) 2008-08-29
NO326356B1 (no) 2008-11-17
NZ501256A (en) 2002-09-27
SK288053B6 (sk) 2013-03-01
CZ302668B6 (cs) 2011-08-24
NZ520652A (en) 2004-06-25
HUP0003634A2 (hu) 2001-07-30
SK602000A3 (en) 2000-07-11
DE69838066T2 (de) 2008-03-20
EA003303B1 (ru) 2003-04-24
IL134045A0 (en) 2001-04-30
IN189035B (no) 2002-12-07
AP1318A (en) 2004-10-22
DK0998291T3 (da) 2007-11-05
TW586926B (en) 2004-05-11
OA11632A (en) 2004-11-22
SI0998291T1 (sl) 2007-12-31
AU8448798A (en) 1999-02-10
DE69838066T3 (de) 2012-03-29
GB9715306D0 (en) 1997-09-24
KR100680667B1 (ko) 2007-02-09
TR200000135T2 (tr) 2000-05-22
DZ2564A1 (fr) 2003-02-15
JP2005247865A (ja) 2005-09-15
SI0998291T2 (sl) 2011-10-28
EP0998291A1 (en) 2000-05-10
CN1264302A (zh) 2000-08-23
PL338127A1 (en) 2000-09-25
EA200000141A1 (ru) 2000-08-28
ES2290989T5 (es) 2011-11-11
MY138246A (en) 2009-05-29
ATE366577T1 (de) 2007-08-15
CY1107745T1 (el) 2013-04-18
UA70302C2 (uk) 2004-10-15
BR9810904A (pt) 2000-09-26
MA26522A1 (fr) 2004-12-20
HUP0003634A3 (en) 2003-04-28
ZA986365B (en) 2000-01-17
PT998291E (pt) 2007-10-11
CO4940422A1 (es) 2000-07-24
CZ2000173A3 (en) 2001-05-16
KR20010021948A (ko) 2001-03-15
HK1029272A1 (en) 2001-03-30
EP0998291B1 (en) 2007-07-11
SK287823B6 (sk) 2011-11-04
ID24198A (id) 2000-07-13
CA2297115A1 (en) 1999-01-28
UY25103A1 (es) 2000-12-29
BG64892B1 (bg) 2006-08-31
WO1999003476A1 (en) 1999-01-28

Similar Documents

Publication Publication Date Title
NO996266D0 (no) Behandling av diabetes tiazolidindion og metformin
DK1174135T3 (da) Farmaceutisk sammensætning omfattende pioglitazon og glimepirid til anvendelse i behandling af diabetes
EE9900328A (et) Tiasooli benseensulfoonamiidid ß3-agonistidena diabeedi ja rasvumuse ravis
FI970357A (fi) Tyypin II diabeteksen hoitoon käyttökelpoisia bensoksatsoli- ja pyridiinijohdannaisia
NO994613D0 (no) Fremgangsmaate og preparat til behandling av sövn-apne
HUP0003876A3 (en) Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes
PT1017408E (pt) Utilizacao de tetra-hidrolipstatina no tratamento de diabetes de tipo ii
NO996265L (no) Behandling av diabetes med rosiglitazon og insulin
DK1001783T3 (da) Behandling af diabetes med thiazolidindion, insulinsekretagog og biguanid
NO996264L (no) Behandling av diabetes med tiazolidindion og sulfonylurea
NO20000229D0 (no) Behandling av diabetes med tiazolidindion og sulfonylurea
NO996270D0 (no) Behandling av diabetes med tiazolidindion og <alfa>- glukosidaseinhibitor
IL133907A0 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
HUP0002668A3 (en) Treatment of diabetes with thiazolidinedione and metformin
HUP0002669A3 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
ID24355A (id) Pengobatan diabetes mellitus dengan tiazolidinadion dan inhibitor alfa-glukosidase

Legal Events

Date Code Title Description
MK1K Patent expired